Vertigo
Vertigo is a form of dizziness that produces a sensation of movement where there is none. When experiencing vertigo, people may feel off-balance like they are spinning and the world around them is moving. Vertigo experiences, especially chronic ones, can be associated with a vestibular disorder in the inner ear.
Chronic vertigo patients can experience severe attacks that can last hours or even days. Vertigo has a large impact on millions of Americans’ daily lives and can prevent people from experiencing a normal life.
These patients may receive diagnoses including, but not limited to: vestibular migraine, Meniere’s disease, benign paroxysmal positional vertigo, or persistent postural perceptive dizziness.
Large Problem,
No Good Solutions
U.S. Vertigo Cases/Yr
4.4 Million ER Visits
U.S. Adult Chronic Patients/Yr
7 Million Vestibular Migraine Patients
%
Miss Work
5.7% Quit Jobs
Our Device
The First Medical Wearable Designed for Vestibular Migraine
7Otolith’s device is a wearable medical device with FDA Breakthrough Designation. Utilizing our non-invasive Vestibular Resonance Therapy or nVRT technology — the Otolith device provides precision signals which may reduce the disorientation handicap in vestibular migraine individuals, allowing them to maintain tasks of daily living.
An estimated 7 million American adults have chronic vertigo related to vertigo from vestibular migraine. Chronic vertigo develops from the inconsistencies in broader vestibular system and the rest of the neural inputs for a person’s usual orientation and/or balance. Symptoms from these chronic conditions can impact daily living through functional, emotional, and physical handicaps.
Chronic Vertigo
A New Idea in a Limited Field of Options
Otolith Labs’ non-invasive technology is being developed for the acute treatment of vertigo episodes in chronic patient population. The headworn device applies localized nVRT stimulation to the vestibular system through precisely calibrated vibrations. It is primarily intended for use by vestibular migraine patients, for whom there are very limited treatments.
nVRT
Designed for Rapid Relief
Otolith Labs has pioneered nVRT technology. Our core technology uses a patented transducer to send consistent and noninformative stimuli to the vestibular system which may mitigate the sensation of vertigo or dizziness.
It has been recorded in clinical studies as reliable and durable. Otolith has made a De Novo submission to the FDA.
200 Massachusetts Ave NW, Floor 7, Washington, DC 20001
© 2026 Otolith Labs, Inc.